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KidneyIdentifying Information Needs of Patients
With IgA Nephropathy Using an Innovative
Social Media–stepped Analytical ApproachCristina Vasilica1, Tom Oates2,3, Christian Clausner1, Paula Ormandy1, Jonathan Barratt4,5
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University of Leicester, Leicester, UKIntroduction: The number of people with kidney disease using social media to search for medical infor-
mation and peer support is increasing. IgA nephropathy (IgAN) predominantly affects young adults,
demographically the biggest users of social media. This article presents an innovative analysis of social
media interactions to identify unmet education and information needs of patients with IgAN.
Methods: Following ethical approval for the study, the IgAN Support UK Facebook group (https://www.
facebook.com/groups/915274415226674) granted us permission to anonymously collect and analyze
1959 posts and comments from 498 group users. An initial patient focus group and quantitative word-
frequency analysis created an initial categorization matrix that was iteratively refined after serial ana-
lyses of the social media database to generate a final categorization matrix of needs. We evaluated
narrative data relating to each identified category to define patient narratives relating to each area.
Results: A large number of information gaps and unanswered questions were identified relating to the
following: diet, symptoms, diagnosis, treatment, and patient comorbidities. Patient–clinician communi-
cation and the presentation of information were also drawn out as cross-cutting issues. These themes
differed significantly from those identified from the traditional patient focus group, highlighting the value
of this novel method for interrogating social media data to understand unmet patient needs.
Conclusion: Social media data are untapped and valuable resources that can be used to better understand
patient information gaps, leading to the generation of targeted materials to address unmet educational
needs. This innovative approach could be replicated across other health conditions.
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ocial networking sites have changed the nature of
the Internet, with people now connected as never
before. In 2019, there were 3.48 billion users of social
media, an increase of 9% versus those in 2018.1 In the
United Kingdom, 86% of adults use the Internet, and
the weekly length of time spent on the Internet has
increased from 9.9 hours in 2005 to 22.9 hours in 2016.2
Improvements in mobile technology mean that social
networks, such as Facebook, Twitter, and Instagram,
have become the preeminent way in which people
communicate and exchange information,3 includingspondence: Matthew Graham-Brown, Department of Car-
scular Sciences, University of Leicester, Leicester LE1 9HN,
-mail: mgb23@le.ac.uk
ved 14 December 2020; revised 9 February 2021; accepted 15
ary 2021
International Reports (2021) -, -–-how patients search for information and support
relating to medical conditions.4 Accessing appropriate,
reliable information through social media and on the
Internet remains a challenge for patients with long-
term conditions.5
The ways we provide information for patients with
chronic kidney disease (CKD) must improve, andwemust
be responsive to the ways people now search for and
share information.6–8 Patients with CKD often express a
desire for increased self-management and self-efficacy,
with many acknowledging the value of other patients’
opinions on their health as a way of learning from others’
experiences.9 There are increasing data revealing that
patients with chronic illnesses make use of social
networking sites to search for information and seek peer
support.10,11 For patients with a rare disease, social media
allows patients to access disease-related information and1
Table 1. Clarification of explained terms
Terms Explanation
Mention The occurrence of a keyword (including derivations) within a post.




Complete counts of all words or phrases used within the social media
database
Posts Comments and messages posted online
Scraping Download of data from Facebook
CLINICAL RESEARCH C Vasilica et al.: Social Media to Identify Patient Needs in IgANconnect with peer support from across the globe when
neither of these resources is available locally.12
IgAN is a rare disease that tends to affect young
patients who are demographically more likely to be
active users of social media. Specific information needs
of patients with IgAN relating to their health are un-
known, and existing educational resources are limited.
In this study, we used an innovative digital method to
anonymously analyze the social media posts and in-
teractions of patients with IgAN to identify and un-
derstand their unmet information needs. We compared
the results of this method with those of a traditional
patient focus group.METHODS
In this study, we collected and anonymously analyzed
the data obtained from the “closed” IgAN Support UK
Facebook group (https://www.facebook.com/groups/
915274415226674). After explicitly discussing with
the group members, the administrators of the IgAN
Support UK Facebook group approved the anonymous
collection and analysis of posts within the group for
the purposes of analysis in line with the study pro-
tocols13 and to the standards recommended by the
Association of Internet Researchers.14 The study
received ethical approval from the University of Sal-
ford (number HSR1617-127). The anonymity of the
group members was protected throughout the study.
No participant data were reported, and all analyses
were conducted without any identifiable information.
No direct quotations were used so as not to inadver-
tently identify participants. Terminology used
throughout the methods and presentation of findings is
clarified in Table 1.
Data Collection and Preparation
Social media posts and associated comments were
scraped (downloaded) using Facebook and Grytics
(Facebook Groups Analytics & Management Tool), for a
2-year period (22 December, 2015–22 December, 2017).
Data were merged into an anonymous database of posts
and related comments. Duplicate posts and associated
demographic information or data that could identify
patients were removed.2
Data Analysis
Data analysis was completed in the following 2 stages
by the multiprofessional research team (Figure 1).
Creation of the Categorization Matrix
The database of Facebook posts and conversations was
analyzed to define a matrix of existing needs, with the
creation of serial categorization matrices that were itera-
tively updated in a structured and unstructured way
(allowing for the identification of new categories) to sys-
tematically make sense of key information categories.15
An initial thematic framework was developed using a
face-to-face patient focus group convened to identify
categories that patients felt were areas of unmet pa-
tient needs (Table 2). The focus group was tran-
scribed, and thematic analysis was undertaken by a
trained qualitative researcher to identify major
themes. This was used to develop the initial catego-
rization matrix (Supplemental Table S1), which was
used for the first interrogation of the social media
database and served as a reference to facilitate a
comparison between the potential needs of patients
with IgAN as defined by a patient focus group
compared with analysis of social media data.
 The social media database was interrogated with a
directed analysis using the predetermined categories
outlined in categorization matrix 1. All posts within
the database that contained words or phrases defined
in categorization matrix 1 were reviewed and further
classified with additional themes added to the matrix.
A summative analysis of the social media data set was
conducted to quantitatively define word/phrase fre-
quency, generating complete counts of all words or
phrases used in the social media database (uninfor-
mative words, such as “the,” “and,” “or,” were
excluded).16 The categorization matrix was updated
with this to create the second categorization matrix
(Supplemental Table S2).
 The database was iteratively reanalyzed to develop
and refine the categorization matrix in an inductive
way based on additional categories and themes
identified each time the data were reanalyzed. These
steps were repeated until no new themes or categories
were identified, and the final categorization matrix
was defined (Supplemental Table S3).
Understanding the Narrative From Identified
Categories
Once the final categorization matrix was created, all
posts containing the words and phrases in the final
categorization matrix and associated conversationsKidney International Reports (2021) -, -–-
Figure 1. Data acquisition and analysis. SoMe, social media.
C Vasilica et al.: Social Media to Identify Patient Needs in IgAN CLINICAL RESEARCHwere read and reviewed by 2 researchers for content,
meaning, and sense to distill the nature of the con-
versation and questions into narratives for each of the
categories and subcategories.
The final summary findings were reviewed by a
multiprofessional research team including patients,
nurses, doctors, dietitians, pharmacists, and health care
assistants to confirm the interpretation of the study
findings and plan educational resources to inform the
knowledge gaps identified.
Data Reliability and Privacy
To increase the reliability of the quantitative frequency
and content analysis, data were interrogated by 2 re-
searchers experienced in the techniques and checked
for accuracy by a third independent researcher.Table 2. Key themes of information identified from initial patient
focus group
Categories Information need
Diagnosis Information on kidney biopsy
Genetics and family testing
Kidney scans
Why some people get hematuria
Disease progression Will my IgAN get worse?





Medications Specific treatments for IgAN
What do the medications I take do?
Experimental trials
Information on disease staging Staging of CKD
The different ways IgAN can affect
kidneys and what this means
Extra support available Support relating to CKD
IgAN support groups
CKD, chronic kidney disease; IgAN, IgA nephropathy.
Kidney International Reports (2021) -, -–-Throughout the analysis sense-checking, face validity
and trustworthiness of the data were confirmed
through consensus review by the study team and pa-
tient representatives. The privacy of the members of
the Facebook group was protected throughout the
study in compliance with the General Data Protection
Requirements (2018), study protocols, and ethical
approval. No direct quotations from original data posts
have been used. Quotations to illustrate study findings
have been modified, so meaning can be inferred, but
anonymity is protected.
RESULTS
A total of 1959 posts and comments were retrieved
from the IgAN Support UK group from 498 different
users, 113 of whom were active users (posted, and/or
commented, and/or reacted to posts in the group dur-
ing the period the data were acquired). The types of
media included in the posts were as follows: text status
update (80%); photo (11%); links to other sites (8%);
and video (1%). A total of 96% of the posts were
commented on or reacted to. Patients were the main
users of the group, but family members and carers were
also included as part of the community.
Major Themes of Unmet Patient Need
The final categories of major unmet need for pa-
tients with IgAN identified through the analysis of
the social media database are shown in Figure 2.
The subcategories relating to each of these themes
and the corresponding number of posts are found
in Table 3. The comparative categories of patient
needs identified from the IgAN patient focus group
are found in Table 2.3
Figure 2. Key categories of unmet patient information needs identified through analysis of social media data.
Table 3. Key themes of information need identified through analysis
of social media data (final summative analysis)
Key categories Information need
Symptom (n ¼ 664) Kidney pain (n ¼ 11)
Pain (n ¼ 132)
Fatigue/tiredness (n ¼ 38)
Blood pressure (n ¼ 95)
Blood (n ¼ 160)
Swelling (edema) (n ¼ 35)
Itchiness (n ¼ 5)
Headaches (n ¼ 15)
Poor sleep/sleep (n ¼ 29)
Others (n ¼ 144)
Diagnosis and medical terminology (n ¼ 464) Kidney function (n ¼ 48)
Stage (n ¼ 72)
Biopsy (n ¼ 77)
GFR (n ¼ 84)
Diagnosis in general (n ¼ 183)
Treatment (n ¼ 329) Medication/drugs (n ¼ 105)
Treatment (n ¼ 57)
Transplant (n ¼ 142)
Others (n ¼ 25)
Diet (n ¼ 235) Salt and potassium (n ¼ 35)
Gluten and diary (n ¼ 20)
Protein (n ¼ 81)
Fish oil (n ¼ 6)
Weight (n ¼ 19)
Others (n ¼ 74)
Support (n ¼ 63) Support (n ¼ 47)
Insurance (n ¼ 16)
Comorbidities (n ¼ 18) Diabetes (n ¼ 9)
Gout (n ¼ 9)
GFR, glomerular filtration rate.
CLINICAL RESEARCH C Vasilica et al.: Social Media to Identify Patient Needs in IgANQualitative analysis of the final posts identified in the
social media analysis identified the following 2 cross-
cutting themes that were subcategorized and analyzed:
 Patient–clinician communication.
 Issues on presentation and trustworthiness of
information.
Qualitative Analysis of Social Media Posts
Relating to Specific Categories and
Subcategories
Narratives related to the categories and subcategories
are discussed subsequently.
Diet
There were 235 diet-related mentions in posts and
comments. Many patients sought information on a
healthy diet and wanted to know whether specific diets
or dietary changes would help manage their disease
and symptoms. Specific areas of diet-related discussion
were as follows:
Protein (n ¼ 81). There was confusion in the posts on
dietary protein. Many patients stated that they had
been explicitly told by medical staff to avoid high-
protein diets, whereas others had been told the
amount of protein intake did not make any difference
to IgAN or progression of CKD.4
Salt and Potassium (n ¼ 35). Many posts were related
to reducing salt intake. Peer-to-peer interactionsKidney International Reports (2021) -, -–-
Table 4. Commonly asked questions around diagnosis and medical
terminology
S. No. Questions
1. What “kidney function” meant?
2. What protein spillage/leakage meant?
3. How was creatinine different to eGFR?
4. The relationship between urinalysis findings and IgAN?
5. What are urine dipsticks for?
6. What did doctors meant when they talked about “PCR?”
7. How is blood pressure related to IgAN and what should it be?
eGFR, estimated glomerular filtration rate; IgAN, IgA nephropathy; PCR, polymerase
chain reaction.
C Vasilica et al.: Social Media to Identify Patient Needs in IgAN CLINICAL RESEARCHacknowledged the difficulties in maintaining a low-salt
diet. Peers reinforced that it was important to adhere to
low-salt diet as it helped the way medications (partic-
ularly blood pressure medications) worked. Specific
advice was sought on low potassium foods.
Gluten and Dairy (n ¼ 20). There were discussions on
whether gluten or dairy-free diets were treatments for
IgAN. Peers discussed possible links between gluten
and autoimmune diseases. Some patients expressed
feeling better on gluten-free and dairy-free diets and
that symptoms improved with these diets. Several
peers counseled that there was no evidence that these
diets improved IgAN, but they were safe to follow.
Weight (n ¼ 19). Patients acknowledged that weight
loss was advisable if you were overweight and aiming
for a “healthyweight.” Peers advised each other that not
being overweight was important if a transplant was
needed. Weight gain was frequently discussed as a side
effect of steroid therapy, but no peer advice was found
to help deal with this. Finally, weight loss was discussed
as a possible way of improving kidney function, but no
consensus was reached on whether weight loss was
beneficial to preserve renal function for patients with
IgAN.
Fish Oil (n ¼ 6). There were discussions on whether
fish oil was beneficial for patients with IgAN, partic-
ularly whether it reduced infections. Some patients
were worried about the potential of fish oil to “thin
their blood,” but others stated that whether it was
beneficial for IgAN or not, eating oily fish was a way of
reducing red meat intake.
Symptoms
There were 647 mentions in all posts related to symp-
toms from, or attributed to, IgAN. Newly diagnosed
patients with IgAN asked for advice on what symp-
toms to expect and sought advice from more experi-
enced patients on managing common symptoms.
Kidney Pain/Pain in General (n ¼ 143). Kidney pain was
described as a pervasive, unwanted symptom. Many
patients suggested that it often followed a viral infec-
tion and wondered whether it was associated with a
decline in kidney function. Some patients were inter-
ested to know whether pain was related to IgAN, but
most wanted advice on controlling the pain as it was
intrusive and unrelenting. Some suggested that dehy-
dration and stress triggered their pain or made it worse.
There was an overwhelming feeling that this symptom
was dismissed by doctors, and many were told un-
equivocally that it was not related to their IgAN.
Recurring advice in the peer support group was to
avoid nonsteroidal anti-inflammatory drugs as these
medications could “make kidney function worse.”Kidney International Reports (2021) -, -–-Fatigue/Tiredness (n ¼ 38). Fatigue and tiredness were
often-discussed symptoms, particularly their relation-
ship with kidney function or phosphate levels. There
were many pieces of peer advice on the importance of
ensuring that hemoglobin and iron levels were well
managed, and reminders were posted to ensure doctors
tested for conditions unrelated to IgAN, such as thy-
roid problems. The impact of fatigue on daily life was
clear, with many describing their being unable to un-
dertake normal activities and lacking energy to exer-
cise. There was acknowledgment from many that blood
pressure medications often made tiredness worse.
Blood Pressure (n ¼ 95). Blood pressure was discussed
in the context of the importance of keeping it under
control and managing its side effects (such as migraine/
tiredness).
Swelling (edema) (n ¼ 35). Patients discussed swelling
as a side effect of medications and swelling relating to
declining kidney function. Patients mentioned the
“moon-face” associated with taking steroids and how it
took time for steroid-related swelling to reduce and the
importance of recording weight and taking “water
tablets” as prescribed.
Itchiness (n ¼ 5). Some patients described itchiness as
a “sign” that their kidney function was dropping.
Several patients noted that the itchiness changed into a
“rash.” No solutions were offered by patients to
manage this symptom.
Headaches (n ¼ 15). Some patients experienced head-
aches on most days and questioned the relationship to
IgAN. Salt intake was reported to worsen headaches.
No consensus was reached in the discussions on the
relationship between headaches and IgAN or CKD.
Poor Sleep/Sleep (n ¼ 29). Many patients acknowl-
edged not being able to sleep well and that sleeping
tablets did not help. There was a suggestion that not
drinking before bedtime might help.
Diagnosis and Medical Terminology
There were 464 posts from patients discussing issues on
the diagnosis of IgAN and the implications of a diag-
nosis of IgAN. Some patients described anxiety before5
CLINICAL RESEARCH C Vasilica et al.: Social Media to Identify Patient Needs in IgANtheir kidney biopsy and relief at getting a diagnosis. A
number of posts were from patients who had received
information on what a kidney biopsy entailed but who
were searching for personal reassurance from peers
about the process.
Table 4 summarizes the posts and questions from
patients asking for explanations of medical terminol-
ogy. These questions were well answered by the peers.
Treatment
Discussions regarding medications and treatments for
IgAN were largely divided into the following 2 groups:
first, patients searching for specific treatments for
IgAN; and second, patients wanting help to deal with
medication side effects.
There were 63 posts on specific treatments for IgAN
and clinical trials. Most patients searching for details of
clinical trials wanted to know if there were trials for
which they might be eligible. A smaller numbers of
patients were interested in understanding more about
complementary therapies. Hyperbaric oxygen and
naturopathic therapies were discussed, but most com-
ments explained that there was no evidence of any
complementary therapies slowing the disease or
relieving symptoms. The use of painkillers was dis-
cussed, with peer advice that nonsteroidal anti-
inflammatory drugs should be avoided in “kidney
disease.” This advice was given regardless of estimated
glomerular filtration rate of a patient (even when
stated). Most patients were searching for advice on
painkiller safety as much as efficacy.
Patients sought peer advice on specific medication
side effects. The major side effects of blood pressure
medications were dizziness, lack of energy, headaches,
and migraines. Patients discussed if the time-of-day
medications were taken would help reduce side ef-
fects. Peers reinforced the importance of taking blood
pressure medications and discussing with doctors
about changing medicines to alleviate symptoms rather
than stopping them altogether. Patients also sought
advice for dealing with side effects from steroids. Most
often reported side effects included facial swelling,
fluid retention, and weight gain. Importantly, most
patients were not seeking answers for why side effects
were common, but they were looking for reassurance
that the side effects were “normal” and advice on how
to manage them. A smaller number of patients made
particular comments about hand tremors and excessive
hair growth with tacrolimus therapy and gastrointes-
tinal side effects from mycophenolate.
There were 230 mentions from patients seeking in-
formation about kidney transplantation and dialysis.
These discussions and conversations were not unique
to IgAN, and patients were looking for information on6
the best time to start dialysis, the benefits of preemp-
tive transplantation, and how to approach discussions
with family and friends on donation. There were a
small number of posts seeking information on exercise
and whether this helped slow or improve IgAN.
Comorbidities
There were 113 posts from patients discussing condi-
tions related to their IgAN, including diabetes, hy-
pertension, and gout. Patients wanted to know if the
conditions were related, and many mentioned that they
had developed diabetes during a course of steroids.
Others stated that they had developed diabetes along-
side their IgAN. The knowledge on management of
diabetes and gout was high, and patients mostly dis-
cussed the conditions as a common part of the patient
experience.
Support
There were 63 posts related to the support of patients
with IgAN. Many posts stated that they had joined the
Facebook group to find support from people with
similar experiences. Many reflected how helpful it was
to share experiences with people who had experienced
similar challenges. When appropriate, group members
referred peers to other support groups, particularly
with questions relating to CKD in general, rather than
questions on IgAN. The inclusion of family and carers
in the group was acknowledged as being important.
There were a smaller number of posts discussing
health, holiday, and life insurance, with practical
support and advice on these issues. Some patients also
indicated that it was difficult to get support from em-
ployers who did not understand the implications of
either CKD or a diagnosis of IgAN. Many patients felt
that clinicians or patient support charities could write
letters to acknowledge the needs and challenges of
patients with CKD and IgAN and that training and
information resources should be available for
employers.
Cross-cutting Themes
There were 2 additional cross-cutting themes identified
spanning the categories.
Patient–Clinician Communication. Peer conversations
frequently highlighted that some of the “traditional
advice” regarding immunosuppression in IgAN was
now considered debatable and that it was hard to be
sure of the current best evidence. There was frustration
that many of the problems patients wanted to discuss
(primarily relating to symptoms) were dismissed by
clinicians, with a common feeling that doctors dis-
missed symptoms they did not know how to deal with
them. Patients frequently stated that they did not mind
if their doctors could not alleviate their symptoms but
that they should acknowledge them. Many felt thatKidney International Reports (2021) -, -–-
C Vasilica et al.: Social Media to Identify Patient Needs in IgAN CLINICAL RESEARCHthis was an issue of time and consultations being too
short.
How to Present Material. A key theme that emerged
was that information did not exist for the questions
that people had, specifically about patients with IgAN.
Many were concerned that often resources did not
seem trustworthy or to be from a reputable source. The
resources people found were often not presented in a
format that was easy to digest, with the use of medical
jargon widespread in the existing IgAN patient
literature.DISCUSSION
This study describes the unmet needs of patients with
IgAN using a novel, digital approach to analysis of
social media data. The categories identified through the
analysis of social media were different from the cate-
gories identified in the patient focus group, empha-
sizing the importance of this digital method as a way of
describing patient experience and needs. The needs
identified were well defined, and we have created an
open-access library of videos with patient partners to
meet these needs (https://www.youtube.com/channel/
UCwZepd8YXUf9RkTYzgH4-cw/videos).
The digital approach we describe differs from
traditional methods for understanding patient needs,
such as focus groups, questionnaires, and patient in-
terviews. Selection and participation bias, ingroup
bias, investigator bias, and limitations of the questions
asked and the way/order they may be asked are all
acknowledged limitations of these techniques.17
Although these limitations can be mitigated by inter-
rater validation, individualized design of qualitative
techniques, and triangulation of methods, hey will
remain in many cases. The digital method we describe
may be free from some of these biases. The social media
data we analyzed were created by users, free of any
investigator agenda or bias, and as such can be
considered an organic, uninfluenced data set of the
conversations and discussions of patients with IgAN.
Furthermore, because the group contained only pa-
tients, family members, and carers, patient posts and
responses were not influenced or modified because of a
preexisting relationship between the individual and
their medical/research team. The database contained
posts from nearly 500 participants, more than 20% of
whom were active users. Focus groups contain a
smaller number of individuals, and although ques-
tionnaires can be given to a large number of in-
dividuals, the responses are limited by the scope of the
questionnaire. Patients who participate in focus groups
for research are often more expert and confident about
being involved in group discussions.18 This isKidney International Reports (2021) -, -–-illustrated in this study by the differences between the
information needs identified by the patient focus group
and the final information needs defined by analysis of
social media data. The information needs identified by
the focus group tended to be more complex than those
identified from social media analysis, perhaps reflecting
a greater knowledge and expertise of those involved in
the focus group. This also indicates that social media
may provide a convenient space where patients with
less knowledge and expertise feel comfortable asking
questions. This is especially important for patients with
a rare disease, for whom the opportunity to find local
support groups is limited.
There were 2 categories of information needs were
identified through this research: information on issues
common to patients with CKD and information needs
specific to patients with IgAN.
Questions on dietary potassium, phosphate, and salt
would be expected of any patient with CKD, whereas
questions on dietary fish oil are likely unique to pa-
tients with IgAN. Although both were found to be
“information needs” for patients with IgAN, it is likely
that information gaps relating to CKD would be com-
mon to all patients with CKD regardless of their pri-
mary disease. This also highlights the complexity for
patients in the way health care professionals refer to
and classify patients with both a primary disease (e.g.,
IgAN) and a syndrome to explain the manifestation of
the disease (e.g., CKD/end-stage kidney disease/
nephrotic syndrome). These definitions are largely for
the convenience of health care professionals to help
with risk stratification and appropriate management
but may be confusing for patients. It is, therefore,
unsurprising that CKD does not permeate public con-
sciousness such as other chronic health conditions. Not
only is CKD a largely invisible condition from the
outside, but the terminology used to discuss it is opa-
que and confusing. This may explain the frustration
patients expressed - that employers had limited un-
derstanding of the implications of a diagnosis of IgAN
or CKD. This needs to be addressed by clinicians and
policy makers with consistent public health messaging.
Many of the conversations related to symptoms
attributed to IgAN or CKD are in keeping with the
symptoms described in patients with CKD.19–21 Often,
these posts expressed frustration that clinicians
frequently dismissed symptoms as being unrelated to
kidney disease or of minimal importance. The peer
support offered in relation to symptom management
was practical and suggested that clinicians did not
address these issues as there are often no good thera-
pies. Although this may be true, these data are a
reminder to clinicians that acknowledgment of patient
concerns is fundamental to their role. Most patients did7
CLINICAL RESEARCH C Vasilica et al.: Social Media to Identify Patient Needs in IgANnot expect a solution to their symptoms but did expect
empathy in how clinicians responded to their concerns
and a balanced psychosocial approach to their personal
challenges.
Limitations
Although the method we describe protects patient
anonymity, the lack of participant-level demographic
data limits the generalizability of the findings; for
example, to know how to correctly respond appropri-
ately to questions about potassium. It also means that
we cannot conduct analyses to identify whether certain
questions were more likely for patients of different
ages, sexes, ethnicities, kidney function, or those with
other factors. This study was conducted in the United
Kingdom, and the IgAN Support UK group was chosen
for this reason. This, again, reduces the generalizability
of the findings, as patient opinions and questions are
invariably “framed” by interactions with clinicians.
There was no mention of tonsillectomy for treatment of
IgAN, for example. Had this study been conducted in a
Japanese Facebook group, this would likely have been
different. This highlights the value of completing
similar studies in different countries and populations.
The digital method we have described allows analysis
of organic, social media content at scale, but there are
potential biases. Although the use of social media is
widespread, there are patients who are not active
Internet/social media users and their views may not be
captured. It is also possible that the views expressed in
groups are subject to ingroup bias, in which certain
individuals lead and control the narrative. In this anal-
ysis, this was not the case as most discussions contained
individuals expressing differing and sometimes
opposing points of view suggesting group members
were able to freely express different opinions and per-
spectives. Indeed, the way this approach identified
discussions between patients is a strength of the study,
highlighting areas where there is a lack of consensus.
Importantly, this digital method is not a replacement for
traditional qualitative study techniques, rather an
additional and complementary method that is applicable
to studying the needs of other patient groups, especially
those with rare diseases.CONCLUSION
This study describes a novel, digital method for the
identification of the unmet needs of patients with IgAN
using analysis of social media data. The findings
highlight important knowledge gaps that can inform
the creation of resources to satisfy these needs. This
method can be applied to the study of patients with a
variety of chronic illnesses.8
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